Many cancer survivors have impairments that make using mobile devices and websites difficult - The Conversation

What the report says

The Conversation Africa reports that cancer survivors can face cognitive, visual and physical impairments that make everyday use of websites, apps and digital devices difficult. The article, written by computer scientists who study accessibility and human-computer interaction, uses the example of “Megan,” a breast cancer survivor who continued to experience memory problems more than 20 years after chemotherapy, including difficulty focusing and following long instructions.

According to the authors, more than 18 million people in the United States are cancer survivors, and many live with lasting functional limitations linked to cancer or treatment. In their study of 46 participants aged 20 to 78, respondents described fatigue, anxiety or depression, cognitive difficulties, dexterity impairments and vision problems after diagnosis and treatment. More than half reported distraction or trouble focusing while using apps and websites, while others cited problems reading text, navigating websites, following instructions, typing, scrolling, clicking or hearing audio.

The article argues that cancer survivors are an underexamined group in software accessibility research. Their challenges may resemble those of older adults or people with disabilities, but can also be distinct: symptoms may appear suddenly, vary over time or continue long after treatment. Dense text, small fonts, low contrast and complex navigation can make routine digital tasks harder, including looking up health information, managing appointments or connecting with support networks.

The authors say relatively straightforward design choices could help, such as larger fonts, clearer contrast, simpler instructions, bullet points, visual cues, zoom options and voice input or output. They also recommend involving cancer survivors in testing and co-design. As survival improves, the article says, digital accessibility should be treated as part of quality of life after cancer.